Skip to content

Manual vs Amigo SmartTouch Atrial Fibrillation Study

Manual vs Amigo SmartTouch Atrial Fibrillation Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01583855
Acronym
MAST-AF
Enrollment
50
Registered
2012-04-24
Start date
2012-03-01
Completion date
2015-02-28
Last updated
2020-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Remote catheter ablation, Atrial fibrillation

Brief summary

Atrial fibrillation is a common form of heart rhythm disturbance that for some patients is treated by catheter ablation (making an ablation lesion or burn inside the heart using a fine wire (catheter)). A new system for manipulating the catheters has recently been introduced into clinical practice (the Amigo Remote Catheter System (RCS)). This trial is designed to answer two primary questions: a) is the contact force (the force with which the catheter comes into contact with the heart) any different using the RCS to manual techniques,and b)are the resulting ablation lesions within the heart any different in terms of the volume and contiguity of the lesions produced. Additionally the investigators aim to determine how the two techniques compare in success (the proportion of patients whose heart rhythm disturbance is corrected by the procedure).

Detailed description

The trial aims to recruit 50 patients, randomised into two groups, to have ablation for atrial fibrillation performed either using the RCS, or manually. Contact force information will be collected during the procedure, but the operators will be blinded to this information. Patients will have follow-up to include post-procedural cardiac magnetic resonance imaging and ambulatory electrocardiograms.

Interventions

PROCEDURECatheter ablation for atrial fibrillation, manual

Ablation for atrial fibrillation will be performed manually

DEVICEAblation using Amigo remote catheter system

Atrial fibrillation ablation will be performed using the Amigo remote catheter system

Sponsors

University of Leicester
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* atrial fibrillation * scheduled for catheter ablation

Exclusion criteria

* contraindication to magnetic resonance imaging * pregnancy * life expectancy of less than six months * participation in another trial that would conflict with this trial

Design outcomes

Primary

MeasureTime frameDescription
Contact force deliveredContact force information collected at the time of the proceduresThe contact force delivered by the catheter is measured and will be compared between the two groups.

Secondary

MeasureTime frameDescription
Quantity and contiguity of ablation lesions3 months post procedureCardiac magnetic resonance will be used to quantify and assess contiguity of ablation lesions.
Recurrence of atrial fibrillation1 yearPatients will be asked to attend office follow-up up to one year post procedure to assess for recurrence of atrial fibrillation.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026